Latest News!! Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study.
{"Image Artist": "Thea Palmer", "Image ExifOffset": "2134", "Image XPAuthor": "Thea Palmer", "Image Padding": "[]", "EXIF DateTimeOriginal": "2020:06:05 20:45:03", "EXIF DateTimeDigitized": "2020:06:05 20:45:03", "EXIF SubSecTimeOriginal": "00", "EXIF SubSecTimeDigitized": "00", "EXIF Padding": "[]"}